AI tumor avatars & digital-twin readiness: computational tumor models integrating multi-omics and clinical context to support hypothesis generation and decision support.
Multi-modal cancer systems biology: integrating genomics, transcriptomics, proteomics and clinical data to map tumor–immune states and actionable mechanisms.
Predictive biomarkers & therapy response modelling: developing computational biomarkers for patient stratification, treatment response and resistance, with a focus on translational validation.
Abdallah M, Nakken S, Georges M, Bierkens M, Galvis J, Groppi A, Karkar S, Meiqari L, Rujano MA, Canham S, Dienstmann R, Fijneman R, Hovig E, Meijer G, Nikolski M(2026) TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching Nat Commun, 17(1) DOI 10.1038/s41467-026-70509-w, PubMed 41876500
Ayuda-Durán P, Hanes R, Rønneberg L, Alver TN, Øy GF, Hauge S, Andersen AN, Egeland EV, Juell S, Nakken S, Asenso TQ, Zucknick M, Syljuåsen RG, Mælandsmo GM, Hovig E, Enserink JM(2026) Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential Commun Med (Lond), 6(1) DOI 10.1038/s43856-026-01583-w, PubMed 42062484
Chica N, Andersen AN, Orellana-Muñoz S, Garcia I, P AN, Nakken S, Ayuda-Durán P, Håkensbakken L, Schultz SW, Rødningen E, Putnam CD, Zucknick M, Rusten TE, Enserink JM(2026) Time-resolved functional genomics using deep learning reveals global hierarchical control of autophagy Nat Cell Biol, 28(3), 465-479 DOI 10.1038/s41556-025-01837-0, PubMed 41826700
